等待开盘 02-06 09:30:00 美东时间
-0.270
-1.43%
CareDx (NASDAQ:CDNA) raises FY2025 sales outlook from $372.000 million-$376.000 million to $380.000 million vs $373.999 million estimate.
01-12 20:07
CareDx (NASDAQ:CDNA) sees Q4 sales of $108.000 million vs $102.584 million analyst estimate.
01-12 20:06
CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
01-07 20:16
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
Wells Fargo analyst Brandon Couillard maintains CareDx (NASDAQ:CDNA) with a Equal-Weight and raises the price target from $14 to $18.
2025-12-16 02:18
CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and
2025-11-25 05:10
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
CareDx shares are trading higher after the company reported better-than-expecte...
2025-11-05 05:53
AI热潮驱动“戴维斯双击”!AMD年内股价狂升110%,Q3营收料增28%至87亿美元,绑定OpenAI加速份额增长,这些指标重点关注>>
2025-10-29 17:51
a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the
2025-10-24 04:18